Garry P. Nolan Ph.d.

Biography

Dr. Garry P. Nolan, Ph.D., is Professor of Microbiology and Immunology, Baxter Laboratory, Stanford University School of Medicine. Dr. Nolan serves as a Director of the Stanford NHLBI Proteomics Center. He is a co-founder of Nodality Inc. He is Founder of BINA Technologies Inc. He is also a Co-founder of three companies, including publicly traded RIGEL and CellGate. He served as an Associate Professor of Microbiology and Immunology (Tenure) at Department of Moelcular Pharmacology of the Stanford University School of Medicine. A leading biotech industry figure, and scientific founder of three pioneering companies, Dr. Nolan is a global leader in single cell analysis. His work is at the forefront of developments at the single cell level using novel genetic and FACS-based approaches. Back at Stanford, Dr. Nolan's laboratory developed efficient viral delivery tools based on retroviruses and lentiviruses (Phoenix and Felix retroviral and lentiviral systems). He developed the first flow-based single cell gene expression analysis system using enzymatic detection with fluorogenic beta-galactosides (FACS-Gal). He worked as a postdoctoral fellow at MIT and Rockefeller University, where he cloned the p65 subunit of NF-kappaB and co-developed the rapid retroviral production systems based on the 293T cell line. Dr. Nolan serves as Chairman of Scientific Advisory Board at Nodality, Inc. and BINA Technologies Inc. He serves as Vice Chairman of PrognosDx Health, Inc. He serves as a Member of the Board of Directors at Nodality, Inc. He serves as a Member of Scientific Advisory Board of Fluidigm Sciences, Inc. He served as a Member of Scientific Advisory Board of Evolva Holding SA., and Intronn, Inc. He serves on the Editorial board of Gene Therapy & Molecular Biology, Cells to Genes and Molecular Therapy (ACS). Dr. Nolan is the author of over 140 peer-reviewed papers and holds numerous issued patents. He is the recipient of several prestigious awards, and was recently honored as one of the top 25 inventors at Stanford University. He was a Hume Faculty Scholar from 1993 to 1998, Trustee of the Leukemia Society of America from 1995 to 1998, Burroughs Welcome Fund New Investigator Awardee from 1996 to 2000, HHMI Junior Faculty Scholar Awardee, Leukemia and Lymphoma Society Stahlman Scholar since 2000. In 2005 he was invited to speak at over 20 conferences and meetings including at MIT, Albert Einstein, Harvard University, Case Western, University of Washington, Williams & Mary Distinguished Speaker, University of Miami, Genentech, Agilent, BMS, Lilly, Janssen, Scripps, Novartis, Serono, ACBS Plenary Session, etc. He served as a Member of Scientific Advisory Board of Evolva A/S. Dr. Nolan received his Ph.D from the Department of Genetics at Stanford at the Herzenberg lab. at Stanford University, and his B.S. in Biology from Cornell University. Dr. Nolan was a postdoctoral fellow in the laboratory of the Nobel laureate Dr. David Baltimore at MIT and Rockefeller University.

Research Interest

 Vaccines & Vaccination